|
|
Article: Risk of Death or Heart Attack With Drug-Eluting Stents Appears Lower With Longer Use of Anti-Clotting Treatment
- Article from:
- U.S. Newswire
- Article date:
- December 5, 2006
CopyrightCopyright 2006 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: National Desk, Health Reporter
Contact: AHRQ Public Affairs, 301-427-1998 or 301-427-1855; Web:
http://www.ahrq.gov
ROCKVILLE, Md., Dec. 5 /U.S. Newswire/ -- Patients who receive
drug-coated stents to open heart arteries may lower their risks of
heart attack or death by taking an anti-platelet medication longer
than current recommendations, according to a study funded by the
Agency for Healthcare Research and Quality and published today in the
online version of JAMA.
The drug, clopidogrel, is an anti-clotting medication currently
recommended for 3 to 6 months after placement of "drug- eluting"
stents. But the new observational study by AHRQ's DEcIDE Research
Center at Duke University ...